Global Immunosuppressants Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Immunosuppressants Market By Drug Class (Corticosteroids, Monoclonal Antibodies, Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Others), Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Immunosuppressants Market

Global immunosuppressants market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the focus of manufacturers on development of variations of immunosuppressants along with having a strong pipeline of therapeutics.

Market Definition: Global Immunosuppressants Market

Immunosuppressants are the class of medical pharmaceuticals that are designed to suppress the immune activity in a patient. These drugs are commonly used in organ transplants, treatment of autoimmune disorders and in some non-autoimmune inflammatory diseases. These drugs help in providing optimal time for patients’ bodies to accept the organ transplant, although it is noted that it can sometimes cause immunodeficiency.

Market Drivers

  • Increasing cases of organ transplants and organ failure incidences in patients acts as a market driver
  • Various innovations and advancements in organ transplantation procedures giving rise to greater volume of these procedures can also drive the growth of this market
  • Higher prevalence of autoimmune disorders and greater population base requiring effective therapies for these diseases is expected to boost the market growth
  • Presence of positive reimbursement scenarios for immunosuppressive therapies can also impede the market growth

Market Restraints

  • Strict regulatory policies and compliances associated with the approval of drugs is expected to restricts the growth of the market
  • Presence of alternative methods of immunosuppression achievement such as stem cell therapy hampers the market growth
  • Absence of information and awareness regarding immunosuppressants can also act as a market restraint

Segmentation: Global Immunosuppressants Market

By Drug Class

  • Corticosteroids
  • Monoclonal Antibodies (mAbs)
  • Calcineurin Inhibitors
  • mTOR Inhibitors
  • Anti-Proliferative Agents
  • Others

By Indication

  • Organ Transplantation
  • Autoimmune Disorders
  • Non-Autoimmune Inflammatory Diseases

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In September 2017, Zydus Cadila announced that they had received the final approval from U.S. FDA for the marketing of “Mycophenolate Mofetil for Injection USP”. The drug has been designed to reduce the prophylaxis of organ rejection for patients receiving renal, cardiac or hepatic transplants, and is indicated to use in combination with cyclosporine and corticosteroids
  • In April 2017, Sanofi announced that they had received U.S. FDA approval for “Thymoglobulin” for use in combination with concomitant immunosuppression in the prophylaxis of patients unable to accept kidney transplant. This approval indicates a strong commitment by the authorities and the manufacturers to develop highly effective therapeutics for reducing the incidences of transplant rejection

Competitive Analysis:

Global immunosuppressants market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunosuppressants market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global immunosuppressants market are GlaxoSmithKline plc; Novartis AG; Sanofi; Bristol-Myers Squibb Company; Pfizer Inc.; Astellas Pharma Inc.; Zydus Cadila; SEBELA PHARMACEUTICALS INC.; Healthy Life Pharma Private Limited; RPG Life Sciences Limited; Akriti Pharmaceuticals Pvt. Ltd.; Intas Pharmaceuticals Ltd. among others.

Research Methodology: Global Immunosuppressants Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global immunosuppressants market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions